Дутов В.В.

The proficiency in managing benign prostatic hyperplasia (BPH) and chronic inflammation of the prostate is a fairly crucial aspect, considering the drastic changes in the approaches to the treatment. According to the relevant estimates, further ageing of the population is expected. The increase in the number of people over 60 will be over 100% in a number of countries(110% in the USAand 160% in Japan); in some cases, the increase is expected to be up to 200% (Canada).

Amputation of the ureter is a complication in which its separation occurs on two levels. The frequency of this complication in the world literature varies from 0.1 to 0.2%. From 2008 to 2015 in the urological clinic MONIKI n. M.F. Vladimirsky 545 years endoscopic operations were performed in 506 patients with ureterolithiasis. In our study, ureteral amputation was noted in one observation (0.2%). One of the possible mechanisms of amputation of the ureter may be the invagination of its wall in the zone of the calculus.

Aim of the study: to evaluate the efficacy of the minimally invasive approaches to the treatment of solitary kidney urolithiasis (ESWL, PCNL, RIRS).

Materials and methods. Study group included 62 patients with ESWL, 49 patients with PCNL and 9 patients with RIRS. Efficacy control included the early post-operative stone related outcomes and the outcomes at 3 months of follow up

Aim: evaluation of the efficacy and safety of the new uroselective alpha-blocker silodosin (Urorec®) in the monotherapy of the patients with the combination of two illnesses: benign prostatic hyperplasia (BPH) and chronic non-infectious prostatitis (CNIP).